Research output per year
Research output per year
Personal profile
Research interests
Prof. David's research integrates polymer chemistry, molecular biology, pharmacology, and biomedical engineering to design innovative therapeutic polymers and nanomedicines for targeted drug delivery, aiming to treat diseases such as cancer, cardiovascular conditions, and liver diseases. Her lab develops polymers that can either bind to disease-specific molecules or adapt their properties at target tissues in response to local stimuli. This interdisciplinary approach supports translational research for precision medicine.
Fingerprint
Dive into the research topics where Ayelet David is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeted Polymer–Peptide Conjugates for E-Selectin Blockade in Renal Injury
Milošević, N., Rütter, M., Ventura, Y., Feinshtein, V. & David, A., 1 Jan 2025, In: Pharmaceutics. 17, 1, 82.Ben-Gurion University of the Negev
Research output: Contribution to journal › Article › peer-review
Open Access -
Dendritic Cell-Targeted Nanoparticles Enhance T Cell Activation and Antitumor Immune Responses by Boosting Antigen Presentation and Blocking PD-L1 Pathways
Srivastava, P., Rütter, M., Antoniraj, G., Ventura, Y. & David, A., 1 Jan 2024, (Accepted/In press) In: ACS Applied Materials and Interfaces.Ben-Gurion University of the Negev
Research output: Contribution to journal › Article › peer-review
-
E-selectin-targeted polymer-doxorubicin conjugate induces regression of established colorectal liver metastases and improves mice survival
Rütter, M., Milošević, N., Ventura, Y., Feinshtein, V. & David, A., 1 Apr 2024, In: Nano Today. 55, 102182.Ben-Gurion University of the Negev
Research output: Contribution to journal › Article › peer-review
-
Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines
Milošević, N., Rütter, M. & David, A., 1 Jan 2022, In: Frontiers in medical technology. 4, 846065.Ben-Gurion University of the Negev
Research output: Contribution to journal › Review article › peer-review
Open Access -
Say no to drugs: Bioactive macromolecular therapeutics without conventional drugs
Rütter, M., Milošević, N. & David, A., 10 Feb 2021, In: Journal of Controlled Release. 330, p. 1191-1207 17 p.Ben-Gurion University of the Negev
Research output: Contribution to journal › Article › peer-review